Evidence-based articles, treatment guides, and the latest news in addiction recovery and mental health.
Eight Minnesota syringe service programs lost their state funding when an HIV prevention grant ended June 30, and several now say closure is imminent.
North Dakota's governor declared a public health emergency and banned kratom sales statewide, effective August 5, as state-level crackdowns on 7-OH accelerate.
Kentucky suspended Medicaid guardrails to expand addiction treatment. A DOJ settlement, an FBI probe, and a $2.3 billion spending surge followed.
SAMHSA announced $73.2 million in grants across three programs: children's mental health services, Zero Suicide implementation, and assisted outpatient treatment.
A new Illinois law folds gambling disorder into the state's Substance Use Disorder Act, unlocking school education, screening, and suicide prevention programs.
Latigo's LTG-001, a selective NaV1.8 inhibitor, beat the opioid comparator in a 343-patient trial — the strongest evidence yet that acute pain may not need opioids.
DEA's inaugural Fentanyl Free America Summit concludes with enforcement results showing over 4 million pills and 1,158 kilograms of fentanyl powder seized in six weeks.
Compass Pathways' COMP360 psilocybin therapy achieves primary endpoints in two Phase 3 trials for treatment-resistant depression, with FDA submission planned for late 2026.
University of Chicago researchers investigate why isolation during teenage years may permanently alter brain development and increase vulnerability to substance use disorders.